Jump: MR Simulation For Radiation Therapy Master Protocol
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT04545957
- Status
- Recruiting
Conditions
- Head and Neck Cancer
- Liver Cancer
- Prostate Cancer
- Recurrent Adenocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MRI Simulator — DEVICERadiation mapping to define the target for radiation.acquiring MR data at the specified timepoint in a patient's care plan and ability to identify the radiation target and develop a radiation therapy plan on the MR data.
- Radiation Therapy — RADIATIONIn Phase I, radiation will be institutional standard per disease site. In Phase II, either radiation according to MR-based dose painting or adjusted RT. These adjusted doses and/or RT will vary per disease site and will be pre-specified in the subprotocols.
Study Details
This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.
Key Dates
- Start date
- Oct 14, 2020
- Status verified
- May 2025
- Primary completion
- Oct 22, 2030
- Completion
- Oct 22, 2030
Study Design
- Enrollment
- 86 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Phase I MRI SimulationThis research study involves a screening period to determine eligibility. \- Radiation mapping to define the target for radiation.acquiring MR data at the specified timepoint in a patient's care plan and ability to identify the radiation target and develop a radiation therapy plan on the MR data.
- Experimental: Phase II MR Simulation Protocol: Track AMR-only Radiation Therapy Simulation MRI-simulation and synthetic CT to plan treatment
- Experimental: Phase II MR Simulation Protocol: Track BAdjusted Margin or / Dose Painted RT Based on Imaging of MR Simulator (e.g. biological imaging or higher resolution imaging)
Primary Outcome Measure
Feasibility of acquiring MRI simulation prior to radiation therapy planning [ Time Frame: 1 Year ]
Central Contacts
- Raymond Mak, MD617-632-5734
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women Hospital | Boston | Massachusetts | 02115 | Raymond Mak, MD Raymond Mak, MD (PRINCIPAL_INVESTIGATOR) |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Raymond Mak, MD Raymond Mak, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
Related Studies
- Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing ProstatectomyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama
- Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell CarcinomaRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts